About: Intetumumab

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Intetumumab is a human monoclonal antibody targeting integrins that was being studied for the treatment of solid tumors. Intetumumab was developed by Centocor, Inc. Phase II clinical trials for treatment of melanoma and prostate cancer were in progress when development of the drug was discontinued.

Property	Value
dbo:abstract	إنتيتوموماب هو جسم مضاد وحيد النسيلة بشري يستخدم في علاج الأورام الصلبة، طورته . (ar) Intetumumab is a human monoclonal antibody targeting integrins that was being studied for the treatment of solid tumors. Intetumumab was developed by Centocor, Inc. Phase II clinical trials for treatment of melanoma and prostate cancer were in progress when development of the drug was discontinued. (en)
dbo:casNumber	725735-28-4
dbo:fdaUniiCode	GQE1BJE2NI
dbo:kegg	D09631
dbo:wikiPageID	33024044 (xsd:integer)
dbo:wikiPageLength	2608 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1053698746 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Melanoma dbr:Monoclonal_antibody dbc:Experimental_cancer_drugs dbr:Prostate_cancer dbc:Janssen_Biotech dbr:Integrin dbr:Centocor
dbp:atcPrefix	none (en)
dbp:c	6468 (xsd:integer)
dbp:casNumber	725735 (xsd:integer)
dbp:chemspiderid	none (en)
dbp:h	10008 (xsd:integer)
dbp:kegg	D09631 (en)
dbp:mabType	mab (en)
dbp:n	1744 (xsd:integer)
dbp:o	2006 (xsd:integer)
dbp:s	40 (xsd:integer)
dbp:source	u (en)
dbp:target	integrin alpha-V (en)
dbp:type	mab (en)
dbp:unii	GQE1BJE2NI (en)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	458270895 (xsd:integer)
dbp:watchedfields	changed (en)
dbp:wikiPageUsesTemplate	dbt:Antineoplastic-drug-stub dbt:Drugbox dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Monoclonal-antibody-stub dbt:Monoclonals_for_tumors
dct:subject	dbc:Experimental_cancer_drugs dbc:Janssen_Biotech
gold:hypernym	dbr:Antibody
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:MonoclonalAntibody yago:WikicatMonoclonalAntibodies yago:Abstraction100002137 yago:Antibody115027189 yago:Chemical114806838 yago:Compound114818238 yago:Macromolecule114944888 yago:Material114580897 yago:Matter100020827 yago:Molecule114682133 yago:MonoclonalAntibody115029781 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Protein114728724 yago:Relation100031921 dbo:Drug yago:Substance100019613 yago:Thing100002452 yago:Unit109465459
rdfs:comment	إنتيتوموماب هو جسم مضاد وحيد النسيلة بشري يستخدم في علاج الأورام الصلبة، طورته . (ar) Intetumumab is a human monoclonal antibody targeting integrins that was being studied for the treatment of solid tumors. Intetumumab was developed by Centocor, Inc. Phase II clinical trials for treatment of melanoma and prostate cancer were in progress when development of the drug was discontinued. (en)
rdfs:label	إنتيتوموماب (ar) Intetumumab (en)
owl:sameAs	freebase:Intetumumab yago-res:Intetumumab wikidata:Intetumumab dbpedia-ar:Intetumumab https://global.dbpedia.org/id/4nrD2
prov:wasDerivedFrom	wikipedia-en:Intetumumab?oldid=1053698746&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:Intetumumab
is dbo:wikiPageWikiLink of	dbr:Integrin_alpha_V dbr:List_of_therapeutic_monoclonal_antibodies dbr:List_of_drugs:_Im–In
is foaf:primaryTopic of	wikipedia-en:Intetumumab